Journal List > J Rheum Dis > v.32(1) > 1516089229

TOOLS
Do, Pyo, Song, Park, and Lee: Erratum: Implication of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis for the first cycle of rituximab: a pilot study in a single Korean center
Erratum

J Rheum Dis 2025;32(1):68-68.

Published online: 1 January 2025

DOI: https://doi.org/10.4078/jrd.22.0033E

Erratum: Implication of serious infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis for the first cycle of rituximab: a pilot study in a single Korean center

Hyunsue Do, M.D.1, Jung Yoon Pyo, M.D.1, 2, Jason Jungsik Song, M.D., Ph.D.1, 2, Yong-Beom Park, M.D., Ph.D.1, 2, Sang-Won Lee, M.D., Ph.D.1, 2,

1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

2Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea

Corresponding author: Sang-Won Lee, https://orcid.org/0000-0002-8038-3341 Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: sangwonlee@yuhs.ac

Copyright © 2025 by The Korean College of Rheumatology. All rights reserved.

(open-access):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
J Rheum Dis 2023;30(1):45-52
We discovered that a missing word in the Figure 1 and would like to correct it.
The corrected version should be as follows:
Before:
Patients with AAV receiving rituximab and having serious infection (n=33)
After:
Patients with AAV receiving rituximab and having no serious infection (n=33)
We sincerely apologize for any confusion that we may have caused.
TOOLS
Similar articles